Daniela Thommen's Avatar

Daniela Thommen

@danielathommen.bsky.social

Precision cancer immunotherapy, T cell immunology, patient-derived tumor immune models | Group leader at NKI and Oncode Institute Amsterdam

1,105 Followers  |  177 Following  |  3 Posts  |  Joined: 19.11.2024  |  1.6944

Latest posts by danielathommen.bsky.social on Bluesky

Congratulations @jacqjacobs.bsky.social @riklindeboom.bsky.social @danielathommen.bsky.social on receiving a ZonMw open competition

26.03.2025 08:20 β€” πŸ‘ 3    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

Very proud of our postdoc @christinamt.bsky.social @nkinl.bsky.social who was awarded an EACR-Mark Foundation Postdoctoral Fellowship! Congratulations to the other awardees and thanks to @helloeacr.bsky.social and @themarkfdn.bsky.social for this fantastic support!

19.03.2025 18:14 β€” πŸ‘ 4    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0

Well done to the first recipients of the EACR-Mark Foundation postdoc fellowships πŸŽ‰πŸŽŠ

And a happy coincidence that all three awardees are women scientists in the labs of three women PIs πŸ™Œ

#WomeninSTEM #WomeninScience πŸ‘©β€πŸ”¬πŸ‘©πŸ»β€πŸ”¬πŸ§ͺ

@themarkfdn.bsky.social
@helloeacr.bsky.social
@juliemmazet.bsky.social

19.03.2025 10:33 β€” πŸ‘ 44    πŸ” 8    πŸ’¬ 0    πŸ“Œ 2
Post image

For those who couldn't attend the new #AACRIO25 meeting, check out our digest here πŸ‘‰ bit.ly/3XvBUkp. We included talks from @jimallisonphd.bsky.social, @danielathommen.bsky.social, @jcstark.bsky.social and more! (1/2)

05.03.2025 16:30 β€” πŸ‘ 3    πŸ” 3    πŸ’¬ 1    πŸ“Œ 0

πŸ“š In conjunction with #ESMOImmuno24, we had our annual #ESMO #IOTECH Editorial Board meeting today - delighted to see many more academics now here πŸ¦‹.

🎯 EiC: @haanenjohn.bsky.social

Section Editors:
@michalbassani.bsky.social (NeoAg/TILs)
@danielathommen.bsky.social (Biomarkers/novel IO targets)...

12.12.2024 19:30 β€” πŸ‘ 5    πŸ” 3    πŸ’¬ 1    πŸ“Œ 0

We are missing you here!

11.12.2024 17:42 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0

🎬 Fantastic start to #ESMOImmuno24 with ESMO-SITC primer. Highlighting challenges of IO biomarker discovery:

πŸ”΄ Heterogeneity in data, samples and assay types
🧬 Need for cross-study harmonisation & tailored composite biomarkers
πŸ’Š Neoadj. trials & PDTF’s offer opportunities for biomarker discovery!

11.12.2024 09:38 β€” πŸ‘ 6    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0

Future PhD students, check out our NKI PhD program: bsky.app/profile/nkin...

29.11.2024 13:16 β€” πŸ‘ 2    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0

Very cool work, congratulations Anna & team!!

28.11.2024 09:46 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

@danielathommen is following 20 prominent accounts